Jilin Aodong Pharmaceutical Group Co Ltd (000623) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥112.12 Million ≈ $16.41 Million USD) by net assets (CN¥30.82 Billion ≈ $4.51 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jilin Aodong Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Jilin Aodong Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Jilin Aodong Pharmaceutical Group Co Ltd total liabilities for a breakdown of total debt and financial obligations.
Jilin Aodong Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jilin Aodong Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Thai Oil Public Company Limited
BK:TOP
|
0.135x |
|
National Beverage Corp
NASDAQ:FIZZ
|
0.047x |
|
WesBanco Inc
NASDAQ:WSBC
|
0.024x |
|
Cohen & Steers Inc
NYSE:CNS
|
0.088x |
|
WNS Holdings Ltd
NYSE:WNS
|
0.037x |
|
GKG Precision Machine Co. Ltd. A
SHE:301338
|
-0.017x |
|
Bains Mer Monaco
PA:BAIN
|
0.073x |
|
Clicks
JSE:CLS
|
0.621x |
Annual Cash Flow Conversion Efficiency for Jilin Aodong Pharmaceutical Group Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Jilin Aodong Pharmaceutical Group Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see Jilin Aodong Pharmaceutical Group Co Ltd (000623) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥29.28 Billion ≈ $4.28 Billion |
CN¥59.48 Million ≈ $8.70 Million |
0.002x | -17.92% |
| 2023-12-31 | CN¥27.50 Billion ≈ $4.02 Billion |
CN¥68.06 Million ≈ $9.96 Million |
0.002x | -84.62% |
| 2022-12-31 | CN¥26.34 Billion ≈ $3.85 Billion |
CN¥423.86 Million ≈ $62.02 Million |
0.016x | +24.03% |
| 2021-12-31 | CN¥25.04 Billion ≈ $3.66 Billion |
CN¥324.85 Million ≈ $47.54 Million |
0.013x | -21.81% |
| 2020-12-31 | CN¥23.53 Billion ≈ $3.44 Billion |
CN¥390.41 Million ≈ $57.13 Million |
0.017x | -1.86% |
| 2019-12-31 | CN¥22.44 Billion ≈ $3.28 Billion |
CN¥379.46 Million ≈ $55.53 Million |
0.017x | +3.32% |
| 2018-12-31 | CN¥21.24 Billion ≈ $3.11 Billion |
CN¥347.64 Million ≈ $50.87 Million |
0.016x | +31.02% |
| 2017-12-31 | CN¥20.54 Billion ≈ $3.01 Billion |
CN¥256.49 Million ≈ $37.53 Million |
0.012x | -29.39% |
| 2016-12-31 | CN¥18.87 Billion ≈ $2.76 Billion |
CN¥333.81 Million ≈ $48.85 Million |
0.018x | -19.85% |
| 2015-12-31 | CN¥17.58 Billion ≈ $2.57 Billion |
CN¥388.03 Million ≈ $56.78 Million |
0.022x | -3.28% |
| 2014-12-31 | CN¥12.66 Billion ≈ $1.85 Billion |
CN¥288.83 Million ≈ $42.26 Million |
0.023x | +20.82% |
| 2013-12-31 | CN¥10.66 Billion ≈ $1.56 Billion |
CN¥201.22 Million ≈ $29.44 Million |
0.019x | -32.39% |
| 2012-12-31 | CN¥9.75 Billion ≈ $1.43 Billion |
CN¥272.40 Million ≈ $39.86 Million |
0.028x | +134.54% |
| 2011-12-31 | CN¥9.09 Billion ≈ $1.33 Billion |
CN¥108.30 Million ≈ $15.85 Million |
0.012x | -50.47% |
| 2010-12-31 | CN¥7.25 Billion ≈ $1.06 Billion |
CN¥174.22 Million ≈ $25.49 Million |
0.024x | -25.95% |
| 2009-12-31 | CN¥6.56 Billion ≈ $959.99 Million |
CN¥213.03 Million ≈ $31.17 Million |
0.032x | -28.95% |
| 2008-12-31 | CN¥5.14 Billion ≈ $752.55 Million |
CN¥235.03 Million ≈ $34.39 Million |
0.046x | -41.87% |
| 2007-12-31 | CN¥4.89 Billion ≈ $716.08 Million |
CN¥384.69 Million ≈ $56.29 Million |
0.079x | -13.70% |
| 2006-12-31 | CN¥2.06 Billion ≈ $302.01 Million |
CN¥187.99 Million ≈ $27.51 Million |
0.091x | +13.05% |
| 2005-12-31 | CN¥1.69 Billion ≈ $247.45 Million |
CN¥136.26 Million ≈ $19.94 Million |
0.081x | -39.83% |
| 2004-12-31 | CN¥1.63 Billion ≈ $238.80 Million |
CN¥218.53 Million ≈ $31.98 Million |
0.134x | +22.53% |
| 2003-12-31 | CN¥1.35 Billion ≈ $197.69 Million |
CN¥147.65 Million ≈ $21.61 Million |
0.109x | +3025.54% |
| 2002-12-31 | CN¥1.22 Billion ≈ $179.23 Million |
CN¥-4.58 Million ≈ $-669.59K |
-0.004x | -103.18% |
| 2001-12-31 | CN¥1.18 Billion ≈ $173.01 Million |
CN¥138.76 Million ≈ $20.31 Million |
0.117x | +68.73% |
| 2000-12-31 | CN¥1.11 Billion ≈ $162.06 Million |
CN¥77.04 Million ≈ $11.27 Million |
0.070x | -54.52% |
| 1999-12-31 | CN¥720.42 Million ≈ $105.42 Million |
CN¥110.18 Million ≈ $16.12 Million |
0.153x | +414.76% |
| 1998-12-31 | CN¥635.85 Million ≈ $93.04 Million |
CN¥-30.90 Million ≈ $-4.52 Million |
-0.049x | -- |
About Jilin Aodong Pharmaceutical Group Co Ltd
Jilin Aodong Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China. The company provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in … Read more